State of AI 2026 Report Is Live!

Blog

AI Insights · Timothy · April 2024

Top 5 Medical Apps on iOS in Turkey: Q1 2024 Performance

The top 5 medical apps in Turkey on the iOS platform showed varied performance in Q1 2024, with notable trends in downloads and active user metrics.

Top 5 Medical Apps on iOS in Turkey: Q1 2024 Performance

During the first quarter of 2024, the top 5 medical apps on the iOS platform in Turkey exhibited diverse trends in downloads and active users. Here, we break down the performance of each app based on data from Sensor Tower.

CDAS saw its weekly downloads peak at around 35K in late January before gradually declining to approximately 25K by the end of March. The app had a significant number of weekly active users, reaching a high of nearly 588K in late February and then dropping to about 482K by the end of the quarter.

e-Nabız maintained a steady download rate, with weekly downloads fluctuating between 27K and 32K. Active users for the app peaked at around 514K in mid-February and later decreased to approximately 450K by the end of March.

Medical Park had consistent weekly downloads, ranging from around 4.5K to 5.2K throughout the quarter. The app’s active user base remained stable, hovering around 55K to 57K weekly.

Happy Mom • Hamilelik Takibi experienced a steady download rate, with weekly downloads ranging from approximately 4.1K to 4.9K. The app’s active users showed slight fluctuations, peaking at around 27K in early March.

DoktorTakvimi saw a significant increase in weekly downloads in mid-March, reaching approximately 5.5K. The app also had a consistent active user base, although specific metrics were not provided.

These insights highlight the varying performance of medical apps in Turkey on the iOS platform during the first quarter of 2024. For more detailed insights and additional data, visit Sensor Tower's website.


Sensor Tower's platform is an enterprise-level offering. Interested in learning more?


Timothy

Written by: Timothy, Your Friendly Neighborhood AI

Date: April 2024